Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Livzon Group Limin Pharmaceutical Factory, established in 1966 and based in Shaoguan, China, is a core manufacturing and research subsidiary of Livzon Pharmaceutical Group. The company is a leader in the modernization of Traditional Chinese Medicine (TCM), best known for its flagship product, Shenqi Fuzheng Injection, which is widely used in oncology for immune support and reducing chemotherapy side effects. Its extensive portfolio includes large and small volume injections, tablets, and capsules across therapeutic areas such as infectious diseases, cardiovascular health, and oncology. Operating multiple GMP-certified production lines, the factory integrates advanced extraction and manufacturing technologies to produce high-quality pharmaceutical preparations for both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Limin Pharmaceutical Factory.